Showing 1 - 10 of 8,323
To investigate how Covid-19 is shaping the way Europeans think about institutions, we conducted a large online survey experiment during the first wave of the epidemic (June). With a randomised survey ow we varied whether respondents are given Covid-related treatment questions first, before...
Persistent link: https://www.econbiz.de/10013251268
To investigate how Covid-19 is shaping the way Europeans think about institutions, we conducted a large online survey experiment during the first wave of the epidemic (June). With a randomised survey ow we varied whether respondents are given Covid-related treatment questions first, before...
Persistent link: https://www.econbiz.de/10012404578
The UK and Sweden have the lowest smoking rates in the European Union as a result of consumers switching from cigarettes to low risk nicotine products. Public Health England and other health organisations have concluded that the health risks of vaping are unlikely to exceed 5% of the risks of...
Persistent link: https://www.econbiz.de/10013223207
The Recovery Fund recently proposed by the EU Commission marks a sea-change in European integration. Yet it will not be enough to meet the challenges Europe faces. There has been much public debate about financing, but little about the sort of concrete projects that the EU should be putting...
Persistent link: https://www.econbiz.de/10012232869
We use quarterly panel data from the COME-HERE survey covering five European countries to analyse three facets of the experience of loneliness during the COVID-19 pandemic. First, in terms of prevalence, loneliness peaked in April 2020, followed by a U-shape pattern in the rest of 2020, and then...
Persistent link: https://www.econbiz.de/10015046159
Persistent link: https://www.econbiz.de/10003449413
Persistent link: https://www.econbiz.de/10003229369
Persistent link: https://www.econbiz.de/10000949223
Very few industries are as profoundly influenced by regulation as the pharmaceutical industry. All aspects of the life-cycle of new drugs are regulated, from patent application, to marketing approval, commercial exploitation, patent expiration and competition with generics. The nature of demand...
Persistent link: https://www.econbiz.de/10012980141